2006 annual financial data

Rigel Pharmaceuticals 2006 Financial results

Direct answer

Revenue was 33,473,000 USD.

Operating income was -43,047,000 USD and net income was -37,637,000 USD.
Operating cash flow was -35,836,000 USD.

Get free Rigel Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
33,473,000 USD
Operating income
-43,047,000 USD
Net income
-37,637,000 USD
Operating cash flow
-35,836,000 USD